Frank Wollheim
41 – 50 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
TNF inhibition as therapy for rheumatoid arthritis.
(
- Contribution to journal › Scientific review
-
Mark
Long term efficacy and safety of cyclosporin versus parenteral old in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension
(
- Contribution to journal › Article
-
Mark
Validecoxib - A viewpoint by Frank A. Wollheim
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
To keep the catch - that is the question: a personal account of the 3rd Annual EULAR Congress, Stockholm.
(
- Contribution to journal › Article
-
Mark
Remicade in der Therapie der rheumatoiden Arthritis und des Morbus Crohn - Kein Grund zur Panik
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CLASS-studien och dess vetenskapliga redovisning. Etiska regler för publicering åsidosatta
(
- Contribution to journal › Article
- 2001
-
Mark
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
(
- Contribution to journal › Article
-
Mark
Cytokines, metalloproteinase, their inhibitors, and COMP: relation to radiological progression and inflammation in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2000
-
Mark
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relations to pulmonary involvement
(
- Contribution to journal › Article
- 1997
-
Mark
HLA DRB1* typing and cartilage oligomeric matrix protein as predictors of joint destruction in recent onset rheumatoid arthritis
(
- Contribution to journal › Article